Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The chromatin remodeler CHD6 promotes colorectal cancer development by regulating TMEM65-mediated mitochondrial dynamics via EGF and Wnt signaling. | Cell Discov | 2022 | 36473865 | PubTator, text mining | PubMed |
| Transcriptomic responses to thermal stress in hybrid abalone (Haliotis discus hannai ♀ × H. fulgens ♂). | Front Genet | 2022 | 36467994 | PubTator, text mining | PubMed |
| In silico analysis of a Skp1 protein homolog from the human pathogen E. histolytica. | J Parasit Dis | 2022 | 36457763 | PubTator, text mining | PubMed |
| Epigenetic modification of miR-217 promotes intervertebral disc degeneration by targeting the FBXO21-ERK signalling pathway. | Arthritis Res Ther | 2022 | 36443856 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases in the acute leukemic signaling pathways. | Front Physiol | 2022 | 36439256 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. | J Hematol Oncol | 2022 | 36434634 | PubTator, text mining | PubMed |
| The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. | Int J Mol Sci | 2022 | 36430960 | PubTator, text mining | PubMed |
| Targeting PTEN Regulation by Post Translational Modifications. | Cancers (Basel) | 2022 | 36428706 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Multiple Myeloma-Cracking the Code to a Better Understanding of the Disease. | Cancers (Basel) | 2022 | 36428668 | PubTator, text mining | PubMed |
| ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. | Cancers (Basel) | 2022 | 36428626 | PubTator, text mining | PubMed |
| Coexpression Network Analysis-Based Identification of Critical Genes Differentiating between Latent and Active Tuberculosis. | Dis Markers | 2022 | 36411825 | PubTator, text mining | PubMed |
| Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress. | Cell Mol Biol Lett | 2022 | 36401206 | PubTator, text mining | PubMed |
| The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage. | J Biol Chem | 2022 | 36395886 | PubTator, text mining | PubMed |
| Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer. | Transl Cancer Res | 2022 | 36388031 | PubTator, text mining | PubMed |
| Systematic analysis of expression profiles and prognostic significance for MMDS-related iron-sulfur proteins in renal clear cell carcinoma. | Sci Rep | 2022 | 36385109 | PubTator, text mining | PubMed |
| Meta-Analysis of EGF-Stimulated Normal and Cancer Cell Lines to Discover EGF-Associated Oncogenic Signaling Pathways and Prognostic Biomarkers. | Iran J Biotechnol | 2022 | 36381277 | PubTator, text mining | PubMed |
| Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). | Oncol Lett | 2022 | 36380875 | PubTator, text mining | PubMed |
| The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection. | J Biol Chem | 2022 | 36379255 | PubTator, text mining | PubMed |
| Inter-Fighting between Influenza A Virus NS1 and β-TrCP: A Novel Mechanism of Anti-Influenza Virus. | Viruses | 2022 | 36366524 | PubTator, text mining | PubMed |
| ORF-Interrupting Mutations in Monkeypox Virus Genomes from Washington and Ohio, 2022. | Viruses | 2022 | 36366490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=29